Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Amortizatization of Intangibles (2016 - 2025)

Ironwood Pharmaceuticals' Amortizatization of Intangibles history spans 11 years, with the latest figure at $435000.0 for Q4 2025.

  • For Q4 2025, Amortizatization of Intangibles rose 8.21% year-over-year to $435000.0; the TTM value through Dec 2025 reached $1.7 million, up 8.34%, while the annual FY2025 figure was $1.7 million, 8.34% up from the prior year.
  • Amortizatization of Intangibles for Q4 2025 was $435000.0 at Ironwood Pharmaceuticals, up from $426000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $435000.0 in Q4 2025 and bottomed at $378000.0 in Q1 2024.